|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
Taysha Gene Therapies, Inc. (TSHA) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30
|
|
Download |
|
|
|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
186,960,000 |
Market
Cap: |
N/A |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$ - $ |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Taysha Gene Therapies is a patient-centric gene therapy company focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the central nervous system in both rare and large patient populations. Co. owns the exclusive worldwide rights to a clinical-stage, intrathecally dosed AAV9 gene therapy program, known as TSHA-120, for the treatment of giant axonal neuropathy (GAN). GAN is a rare autosomal recessive disease of the central and peripheral nervous systems caused by loss-of-function gigaxonin gene mutations. TSHA-120 is an AAV9 self-complementary viral vector encoding the full length human gigaxonin protein.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
100,000 |
17,905,000 |
19,405,000 |
Total Buy Value |
$0 |
$163,000 |
$16,186,400 |
$19,186,400 |
Total People Bought |
0 |
1 |
5 |
5 |
Total Buy Transactions |
0 |
1 |
7 |
8 |
Total Shares Sold |
0 |
0 |
582,095 |
677,095 |
Total Sell Value |
$0 |
$0 |
$465,624 |
$813,892 |
Total People Sold |
0 |
0 |
2 |
3 |
Total Sell Transactions |
0 |
0 |
7 |
16 |
End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Alam Kamran |
CHIEF FINANCIAL OFFICER |
|
2024-02-02 |
4 |
D |
$1.51 |
$1,945 |
D/D |
(1,288) |
840,937 |
|
- |
|
Alam Kamran |
Chief Financial Officer |
|
2024-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
590,413 |
842,225 |
|
- |
|
Nolan Sean P. |
Chief Executive Officer |
|
2024-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
1,184,688 |
1,185,858 |
|
- |
|
Nagendran Sukumar |
President and Head of R&D |
|
2024-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
863,617 |
897,843 |
|
- |
|
Manning Paul B |
10% Owner |
|
2023-11-17 |
4 |
B |
$1.63 |
$163,000 |
I/I |
100,000 |
16,566,667 |
1.5 |
- |
|
Alam Kamran |
Chief Financial Officer |
|
2023-08-24 |
4 |
AS |
$2.33 |
$76,890 |
D/D |
(33,000) |
258,042 |
|
- |
|
Manning Paul B |
10% Owner |
|
2023-08-16 |
4 |
B |
$0.90 |
$14,820,000 |
I/I |
16,466,667 |
16,466,667 |
1.5 |
- |
|
Nolan Sean P. |
Chief Executive Officer |
|
2023-08-16 |
4 |
B |
$0.90 |
$400,000 |
I/I |
444,444 |
1,535,545 |
2.66 |
- |
|
Stalfort Sean |
Director |
|
2023-08-16 |
4 |
GA |
$0.00 |
$0 |
D/D |
50,000 |
1,049,381 |
|
- |
|
Stalfort Sean |
Director |
|
2023-08-16 |
4 |
B |
$0.90 |
$350,000 |
D/D |
388,889 |
999,381 |
2.39 |
- |
|
Stalfort Sean |
Director |
|
2023-08-16 |
4 |
B |
$0.90 |
$350,000 |
I/I |
388,889 |
884,290 |
2.1 |
- |
|
Donenberg Philip B |
Director |
|
2023-08-16 |
4 |
B |
$0.90 |
$100,000 |
D/D |
111,111 |
114,111 |
2.39 |
- |
|
Session R.a. Ii |
|
|
2023-07-13 |
4 |
S |
$0.70 |
$3,741 |
D/D |
(5,344) |
8,871,747 |
|
- |
|
Session R.a. Ii |
|
|
2023-07-12 |
4 |
S |
$0.71 |
$57,030 |
D/D |
(80,528) |
8,877,091 |
|
- |
|
Session R.a. Ii |
10% Owner |
|
2023-06-23 |
4 |
S |
$0.70 |
$12,735 |
D/D |
(18,100) |
8,957,619 |
|
- |
|
Stalfort Sean |
Director |
|
2023-06-22 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
495,401 |
|
- |
|
Stalfort Sean |
Director |
|
2023-06-22 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
610,492 |
|
- |
|
Session R.a. Ii |
10% Owner |
|
2023-06-22 |
4 |
S |
$0.70 |
$7,384 |
D/D |
(10,508) |
8,975,719 |
|
- |
|
Session R.a. Ii |
10% Owner |
|
2023-06-21 |
4 |
S |
$0.70 |
$97,635 |
D/D |
(138,962) |
8,986,227 |
|
- |
|
Session R.a. Ii |
10% Owner |
|
2023-06-20 |
4 |
S |
$0.71 |
$210,209 |
D/D |
(295,653) |
9,125,189 |
|
- |
|
Alam Kamran |
Chief Financial Officer |
|
2023-05-31 |
4 |
A |
$0.00 |
$0 |
D/D |
6,230 |
291,042 |
|
- |
|
Nagendran Sukumar |
President and Head of R&D |
|
2023-05-16 |
4 |
B |
$0.68 |
$3,400 |
D/D |
5,000 |
34,226 |
2.73 |
- |
|
Session R.a. Ii |
10% Owner |
|
2023-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
251,296 |
9,420,842 |
|
- |
|
Alam Kamran |
Chief Financial Officer |
|
2023-02-02 |
4 |
A |
$0.00 |
$0 |
D/D |
18,691 |
284,812 |
|
- |
|
Manning Paul B |
Director |
|
2022-10-31 |
4 |
B |
$2.00 |
$3,000,000 |
D/D |
1,500,000 |
1,642,202 |
3.92 |
- |
|
59 Records found
|
|
Page 1 of 3 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|